A June 2026 study from the Endocrine Society (presented at ENDO 2026), one of the first to use wearable fitness tracker data in a large GLP-1 cohort, found that people on GLP-1 medications - including Ozempic, Wegovy, Mounjaro, and Zepbound - actually reduced their physical activity compared to baseline, making intentional resistance training tracking even more relevant for this population
Employers can also ease costs by funding taxadvantaged accounts such as health flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), or health savings accounts (HSAs) that may reimburse GLP1 drugs when prescribed to treat a diagnosed condition such as obesity or heart disease
In their healthy state, astrocytes remain indispensable for neuronal support, but their metabolic roles in both health and disease continue to be an active area of research with significant therapeutic potential
For extra day-to-day support, Weight Loss Boost is designed for energy support during weight loss
Dietary supplements produce varying responses across individuals, and no specific outcomes are guaranteed
